A citation-based method for searching scientific literature

Vedell Louis Jeune, Jakob A Joergensen, Roger J Hajjar, Thomas Weber. Hum Gene Ther Methods 2013
Times Cited: 151







List of co-cited articles
1303 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benveniste, Marie Françoise Montus, Carole Masurier. Hum Gene Ther 2010
541
39

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Catherine S Manno, Glenn F Pierce, Valder R Arruda, Bertil Glader, Margaret Ragni, John J Rasko, Margareth C Ozelo, Keith Hoots, Philip Blatt, Barbara Konkle,[...]. Nat Med 2006
35

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington,[...]. N Engl J Med 2011
30

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
762
27

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, W Dave Arnold, Louise R Rodino-Klapac, Thomas W Prior, Linda Lowes, Lindsay Alfano, Katherine Berry, Kathleen Church,[...]. N Engl J Med 2017
994
27

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
372
22

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
364
22

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.
Roberto Calcedo, Luk H Vandenberghe, Guangping Gao, Jianping Lin, James M Wilson. J Infect Dis 2009
470
22


Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Christian Hinderer, Nathan Katz, Elizabeth L Buza, Cecilia Dyer, Tamara Goode, Peter Bell, Laura K Richman, James M Wilson. Hum Gene Ther 2018
314
20

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial.
Céline Vandamme, Oumeya Adjali, Federico Mingozzi. Hum Gene Ther 2017
118
19

Overcoming preexisting humoral immunity to AAV using capsid decoys.
Federico Mingozzi, Xavier M Anguela, Giulia Pavani, Yifeng Chen, Robert J Davidson, Daniel J Hui, Mustafa Yazicioglu, Liron Elkouby, Christian J Hinderer, Armida Faella,[...]. Sci Transl Med 2013
191
18

Adeno-associated virus vector as a platform for gene therapy delivery.
Dan Wang, Phillip W L Tai, Guangping Gao. Nat Rev Drug Discov 2019
557
16

Adeno-associated virus antibody profiles in newborns, children, and adolescents.
Roberto Calcedo, Hiroki Morizono, Lili Wang, Robert McCarter, Jianping He, David Jones, Mark L Batshaw, James M Wilson. Clin Vaccine Immunol 2011
183
15


Clades of Adeno-associated viruses are widely disseminated in human tissues.
Guangping Gao, Luk H Vandenberghe, Mauricio R Alvira, You Lu, Roberto Calcedo, Xiangyang Zhou, James M Wilson. J Virol 2004
685
15

CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Federico Mingozzi, Marcela V Maus, Daniel J Hui, Denise E Sabatino, Samuel L Murphy, John E J Rasko, Margaret V Ragni, Catherine S Manno, Jurg Sommer, Haiyan Jiang,[...]. Nat Med 2007
489
15

Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig,[...]. Blood 2018
159
14

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
Amine Meliani, Florence Boisgerault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Severine Charles,[...]. Nat Commun 2018
116
14

Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.
Ciaran D Scallan, Haiyan Jiang, Tongyao Liu, Susannah Patarroyo-White, Jurg M Sommer, Shangzhen Zhou, Linda B Couto, Glenn F Pierce. Blood 2006
184
13

Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
C Li, N Narkbunnam, R J Samulski, A Asokan, G Hu, L J Jacobson, M J Manco-Johnson, P E Monahan. Gene Ther 2012
132
13

Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion.
Longping Victor Tse, Kelli A Klinc, Victoria J Madigan, Ruth M Castellanos Rivera, Lindsey F Wells, L Patrick Havlik, J Kennon Smith, Mavis Agbandje-McKenna, Aravind Asokan. Proc Natl Acad Sci U S A 2017
94
13

A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.
Virginie Monteilhet, Samir Saheb, Sylvie Boutin, Christian Leborgne, Philippe Veron, Marie-Françoise Montus, Philippe Moullier, Olivier Benveniste, Carole Masurier. Mol Ther 2011
108
13

Emerging Issues in AAV-Mediated In Vivo Gene Therapy.
Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi. Mol Ther Methods Clin Dev 2017
359
13

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, Laetitia van Wittenberghe, Alban Vignaud, Fanny Collaud, Séverine Charles, Marcelo Simon Sola,[...]. Mol Ther Methods Clin Dev 2018
83
15


A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
12

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Jean-Charles Nault, Shalini Datta, Sandrine Imbeaud, Andrea Franconi, Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati, Benjamin Verret, Jean-Frédéric Blanc,[...]. Nat Genet 2015
275
11

Effect of genome size on AAV vector packaging.
Zhijian Wu, Hongyan Yang, Peter Colosi. Mol Ther 2010
463
11

Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Nicole K Paulk, Katja Pekrun, Erhua Zhu, Sean Nygaard, Bin Li, Jianpeng Xu, Kirk Chu, Christian Leborgne, Allison P Dane, Annelise Haft,[...]. Mol Ther 2018
92
11

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
Leszek Lisowski, Allison P Dane, Kirk Chu, Yue Zhang, Sharon C Cunningham, Elizabeth M Wilson, Sean Nygaard, Markus Grompe, Ian E Alexander, Mark A Kay. Nature 2014
265
11

Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.
Haiyan Jiang, Linda B Couto, Susannah Patarroyo-White, Tongyao Liu, Dea Nagy, Joseph A Vargas, Shangzhen Zhou, Ciaran D Scallan, Jurg Sommer, Sharmila Vijay,[...]. Blood 2006
220
11

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
700
11


Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.
L G Chicoine, C L Montgomery, W G Bremer, K M Shontz, D A Griffin, K N Heller, S Lewis, V Malik, W E Grose, C J Shilling,[...]. Mol Ther 2014
87
12

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.
Michael F Naso, Brian Tomkowicz, William L Perry, William R Strohl. BioDrugs 2017
433
11

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
Narendra Maheshri, James T Koerber, Brian K Kaspar, David V Schaffer. Nat Biotechnol 2006
342
11

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.
Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo, Joseph E Rabinowitz. Mol Ther 2008
817
11

Engineering adeno-associated virus vectors for gene therapy.
Chengwen Li, R Jude Samulski. Nat Rev Genet 2020
264
11

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Christian Leborgne, Elena Barbon, Jeffrey M Alexander, Hayley Hanby, Sandrine Delignat, Daniel M Cohen, Fanny Collaud, Saghana Muraleetharan, Dan Lupo, Joseph Silverberg,[...]. Nat Med 2020
88
12

Strategy to detect pre-existing immunity to AAV gene therapy.
L Falese, K Sandza, B Yates, S Triffault, S Gangar, B Long, L Tsuruda, B Carter, C Vettermann, S J Zoog,[...]. Gene Ther 2017
43
23


Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
Guang-Ping Gao, Mauricio R Alvira, Lili Wang, Roberto Calcedo, Julie Johnston, James M Wilson. Proc Natl Acad Sci U S A 2002
10

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
Dirk Grimm, Joyce S Lee, Lora Wang, Tushar Desai, Bassel Akache, Theresa A Storm, Mark A Kay. J Virol 2008
397
10

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Kevin D Foust, Emily Nurre, Chrystal L Montgomery, Anna Hernandez, Curtis M Chan, Brian K Kaspar. Nat Biotechnol 2009
841
10

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors.
Anita Kruzik, Damir Fetahagic, Bettina Hartlieb, Sebastian Dorn, Herwig Koppensteiner, Frank M Horling, Friedrich Scheiflinger, Birgit M Reipert, Maurus de la Rosa. Mol Ther Methods Clin Dev 2019
50
20

Basic biology of adeno-associated virus (AAV) vectors used in gene therapy.
Balaji Balakrishnan, Giridhara R Jayandharan. Curr Gene Ther 2014
84
10

Engineering adeno-associated viruses for clinical gene therapy.
Melissa A Kotterman, David V Schaffer. Nat Rev Genet 2014
460
9

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan Elci, Sarah McCague,[...]. Lancet 2017
725
9

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.
Benjamin E Deverman, Piers L Pravdo, Bryan P Simpson, Sripriya Ravindra Kumar, Ken Y Chan, Abhik Banerjee, Wei-Li Wu, Bin Yang, Nina Huber, Sergiu P Pasca,[...]. Nat Biotechnol 2016
467
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.